U.S. Burn Care Centers Market to Reach Around USD 11.67 Bn by 2033

The U.S. burn care centers market size was valued at USD 8.14 billion in 2023 and is anticipated to reach around USD 11.67 billion by 2033, growing at a CAGR of 3.67% from 2024 to 2033.

Download Free Sample Copy for Better Understanding@ https://www.novaoneadvisor.com/report/sample/8481

Key Takeaways:

• Based on facility type, the market is bifurcated into in-hospital and standalone. The standalone segment dominated with the largest revenue share of 59.15% in 2023 and is expected to witness the fastest growth over the forecast period.
• Based on procedure type, the wound debridement segment dominated the market with the largest revenue share of 35.37% in 2023.
• The skin graft segment is expected to witness the fastest growth over the forecast period.
• Based on burn severity, the partial-thickness burns segment dominated with the largest revenue share of 66.22% in 2023.
• The full-thickness burn severity segment is expected to register the fastest CAGR over the forecast period.
• Based on service type, the inpatient service segment dominated with the largest revenue share of 87.11% in 2023 and is expected to witness the fastest growth over the forecast period.
• The Southeast U.S. region dominated with the largest revenue share of 21.48% in 2023.
• The Northeast region is expected to witness the fastest growth over the forecast period.

U.S. Burn Care Centers Market Growth

Some of the major factors driving market expansion include an increase in burn-related Emergency Department (ED) visits and hospital admissions, primarily due to partial-thickness or second-degree burns. Favorable reimbursement rules for burn treatment, greater government programs for emergency medical aid, and efforts to reduce needless fatalities are all projected to drive up demand for treatment and care.

Hospitals in the United States are increasing the number of new burn care units in their facilities, which is projected to fuel market expansion. As hospital facilities expand, so does the number of burn procedures performed in-house, including wound debridement, skin grafting, and respiratory intubation and ventilation. The number of in-hospital facilities in the country is expected to increase from 121 in 2017 to around 128 in 2018. However, the number of in-hospital treatment centers in the United States is expected to reach over 4,500 by the end of 2018. According to the American Hospital Association, community hospitals saw 1,280 bed admissions in 2020.

Furthermore, the market is likely to be driven by increased investments in hospital upgrades, the development of new treatment units, and the establishment of new freestanding facilities around the country. For example, in March 2023, Tampa General Hospital unveiled its freshly upgraded regional center, which includes an integrated specialist Intensive Care Unit (ICU) built for the critical care of burn victims. Growing activities done by government organizations such as the World Health Organization (WHO) and nonprofit organizations, including the American Burn Association (ABA), have significantly contributed to raising knowledge about preventive and cure protocols, resulting in favorable market growth.

The American Burn Association has proclaimed National Burn Awareness Week 2021, with the subject "Electrical Safety from Amps to Zap." With over 400,000 people treated annually for injuries, particularly those affecting children, we are submitting a bipartisan resolution to acknowledge center efforts and promote awareness during this week. The campaign focuses on electrical safety, namely unsecured outlets, inappropriate extension cable use, lightning, and workplace mishaps. The purpose is to bring together educators to share preventative messages and save lives. Most therapies are expensive and only conducted at high-end treatment centers. These treatment centers, which have higher disinfection requirements within their units, are in higher demand than alternatives like as in-hospital facilities.

Burn injuries have higher costs than many other well-known health conditions. This may limit growth during the anticipated timeframe. During the pandemic, the overall capacity was reduced by one-third of its former size, especially during the lockdown period. The psychological repercussions of the COVID-19 pandemic are expected to have a long-term impact on the US market, encouraging the further expansion of telehealth services such as virtual visits and video consultations. Furthermore, most treatment institutions have accepted the "new normal," equipping their departments and wards with disinfection methods and protective resources to aid in emergency situations.

U.S. Burn Care Centers Market By Service Type Insights

Based on service type, the market is segmented into inpatient, outpatient, and rehabilitation. The inpatient service segment dominated with the largest revenue share of 87.11% in 2023 and is expected to witness the fastest growth over the forecast period. This can be attributed to a rise in hospital admissions for victims. In addition, the high costs associated with inpatient services are resulting in the segment's growth as the number of hospital admissions and ED visits is witnessing a declining trend.

U.S. Burn Care Centers Market By Facility Type Insights

Based on facility type, the market is bifurcated into in-hospital and standalone. The standalone segment dominated with the largest revenue share of 59.15% in 2023 and is expected to witness the fastest growth over the forecast period. The growth can be attributed to the increasing number of patients preferring personalized care and value-based services over quantity-oriented offerings. Another reason driving the segment is the presence of more beds in freestanding facilities for long-term care of victims compared to in-hospital care. Furthermore, standalone units have specialty doctors and nurses who provide superior quality care, which results in fewer infections. Thus, the majority of patients prefer to seek treatment from these facilities.

U.S. Burn Care Centers Market By Procedure Type Insights

Based on procedure type, the market is segmented into wound debridement, skin graft, wound management, respiratory intubation and ventilation, pain management, blood transfusion, infection control, and rehabilitation. The wound debridement segment dominated the market with the largest revenue share of 35.37% in 2023. For most patients, various wound debridement procedures, such as mechanical, enzymatic, autolysis, and surgical, are performed in centers. Among these methods, surgical debridement stands out as the most frequently executed procedure due to its quick application and suitability for various types of wounds.

U.S. Burn Care Centers Market By Burn Severity Insights

Based on burn severity, the market is segmented into minor burns, partial-thickness burns, and full-thickness burns. The partial-thickness burns segment dominated with the largest revenue share of 66.22% in 2023. Commonly referred to as second-degree burns, this category affects the skin's epidermis layer. Such injuries typically stem from chemicals, flames, scalding incidents, sunburn, and electrical exposure.

Within treatment facilities and care units in the U.S., the management of partial-thickness burns constitutes a significant revenue source. The severity of the injury determines the treatment approach, encompassing prolonged observation care and additional services as required. The partial-thickness wound treatment market has grown quickly over the past few years due to a rising annual count of hospitalized patients attributed to partial burns. The rising occurrence of such injuries among pediatric and adult populations is anticipated to further fuel the growth of this segment.

U.S. Burn Care Centers Market By Region Insights

Based on region, the market is segmented into Northeast, Southeast, Southwest, Midwest, and West. The Southeast U.S. region dominated with the largest revenue share of 21.48% in 2023. The region’s convenient location makes it easy for people from nearby areas to reach it for medical treatment. The rising investments in healthcare infrastructure, including state-of-the-art burn care facilities, advanced medical technologies, and skilled healthcare professionals have bolstered the region's capability to provide specialized burn care services, attracting patients seeking quality treatment. Collaborative efforts between healthcare institutions, research centers, and government initiatives have contributed to the growth of centers in the southeast region.

The Northeast region is expected to witness the fastest growth over the forecast period. This can be attributed to the area's concentration of renowned medical institutions and specialized healthcare facilities. The presence of a strong healthcare infrastructure, combined with a concentration of proficient medical experts and cutting-edge technologies, has established a favorable setting for delivering comprehensive and top-tier care services.

U.S. Burn Care Centers Market Top Key Companies:

• Brigham and Women’s Hospital
• LAC+USC Medical Burn Center
• MedStar Health (MedStar Washington Hospital Center)
• The Ohio State University Wexner Medical Center
• Parkland Health
• Dignity Health (Saint Francis Memorial Hospital Bothin Burn Center)
• RWJBarnabas Health (St. Barnabas Burn Center))
• Temple University Health System, Inc. (Temple University Hospital Adult Burn Center)
• UMC Lions Burn Center
• The University of Chicago Medical Center (University of Chicago Burn Center)
• Jackson Health System (University of Miami Jackson Memorial Hospital Burn Center)
• Weill Cornell Medicine (Weill Cornell Medicine William Randolph Hearst Burn Center)

U.S. Burn Care Centers Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Burn Care Centers market.

By Facility Type?

• In-hospital
• Standalone

By Procedure Type?

• Wound Debridement
• Skin Graft
• Wound Management
• Respiratory Intubation & Ventilation
• Blood Transfusion
• Pain Management
• Infection Control
• Rehabilitation

By Burn Severity?

• Minor Burns
• Partial Thickness Burns
• Full Thickness Burns

By Service Type?

• Inpatient
• Outpatient
• Rehabilitation

By Regional?

• Northeast
• Southeast
• Southwest
• Midwest
• West

Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/8481 ?

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333

About US

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Connect with Us

Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India

Call: USA - + 1 804 441 9344| IND - + 91 87933 22019 | Europe: +44 2080772818

[email protected]

Web: https://www.novaoneadvisor.com/

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to com

Nova One Advisor Group Offer Other Reports:

Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.

Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.

Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.

Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.

U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.

U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.

T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.

Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market?size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.

Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.

Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.

U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.

Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.

Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.

U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.

Compounding Pharmacies Market :?The global compounding pharmacies market size?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.

U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.

Antibiotics Market: The?global antibiotics market size?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.

Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.

Genome Editing Market ;?The?global genome editing market size?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.

U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.

U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.

Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.

Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.

U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.